Yoda M, Nonoyama M, Shimakura T, Morishita A, Takasaki T
Department of Cardiovascular Surgery, Fukuyama Circulation Hospital, Fukuyama, Japan.
Kyobu Geka. 2003 Jun;56(6):479-82.
Preoperative autologous blood donation is commonly used to reduce exposure to homologous blood transfusions among patients undergoing elective cardiac surgery. The purpose of this study was to ascertain how much volume of predonated autologous blood need to avoid of homologous blood transfusion in cardiac procedure.
One hundred twenty-eight patients underwent scheduled cardiac procedure between January 1998 and December 1999. Group 1: 400 ml predonated, operation without cardiopulmonary bypass (CPB) [n = 33], group 2: 800 ml predonated, operation without CPB (n = 23), group 3: 800 ml predonated, operation with CPB (n = 36), group 4: 1,200 ml predonated, operation with CPB (n = 36). Surgical procedures underwent only off-pump coronary artery bypass grafting (OPCAB) in groups 1 and 2. In groups 3 and 4 included coronary artery bypass grafting (CABG), valve replacement, CABG + valve replacement and atrial septal defect repair.
There were no significant differences in mean body weight, mean preoperative hematocrit values or mean volume of intraoperative blood loss between groups 1 and 2. There were no significant differences in mean age, mean body weight, mean preoperative and postoperative day-7 hematocrit values, mean volume of intraoperative blood loss or mean CPB time between groups 3 and 4. The mean postoperative day-7 hematocrit value was significantly lower in group 1 than in group 2. Homologous blood transfusion was avoided in 63.6% of those with predonation of group 1 versus 100% at group 2 (p < 0.05), 86.1% at group 3 versus 94.4% at group 4 (p < 0.05). In group 3, all patients who underwent redo operation or CABG + valve replacement needed homologous blood transfusion.
Autologous blood transfusion is effective for reducing the homologous blood requirement. It also seems that predonation of 800 ml may be sufficient to avoid homologous blood transfusion in cardiac surgery, however predonation of 1,200 ml is desirable in cases of redo operation or CABG + valve replacement.
术前自体输血常用于减少择期心脏手术患者接受异体输血的情况。本研究的目的是确定在心脏手术中需要预存多少自体血才能避免异体输血。
1998年1月至1999年12月期间,128例患者接受了计划性心脏手术。第1组:预存400ml,非体外循环(CPB)手术[n = 33];第2组:预存800ml,非体外循环手术(n = 23);第3组:预存800ml,体外循环手术(n = 36);第4组:预存1200ml,体外循环手术(n = 36)。第1组和第2组仅进行非体外循环冠状动脉搭桥术(OPCAB)。第3组和第4组包括冠状动脉搭桥术(CABG)、瓣膜置换术、CABG + 瓣膜置换术和房间隔缺损修复术。
第1组和第2组之间的平均体重、术前平均血细胞比容值或术中平均失血量无显著差异。第3组和第4组之间的平均年龄、平均体重、术前和术后第7天的平均血细胞比容值、术中平均失血量或平均CPB时间无显著差异。第1组术后第7天的平均血细胞比容值显著低于第2组。第1组预存自体血的患者中63.6%避免了异体输血,而第2组为100%(p < 0.05);第3组为86.1%,第4组为94.4%(p < 0.05)。在第3组中,所有接受再次手术或CABG + 瓣膜置换术的患者都需要异体输血。
自体输血对于减少异体血需求是有效的。似乎预存800ml可能足以避免心脏手术中的异体输血,然而,在再次手术或CABG + 瓣膜置换术的情况下,预存1200ml是可取的。